Literature DB >> 262595

Genital lesions in experimental chronic Trypanosoma brucei infection in rams.

B O Ikede.   

Abstract

Rams inoculated intravenously with Trypanosoma brucei developed scrotal oedema and a nonsuppurative granulomatous periorchitis resulting in testicular degeneration, atrophy, calcification and sclerosis. The tunica vaginalis was the seat of an intense granulomatous inflammation and focal necrosis, which extended to the epididymis and spermatic cord. Lesions in the seminal vesicles were suggestive of diminished testosterone production even though Leydig cells were discernible in the sclerotic testicular intertubular tissue. In areas where there was inflammation or focal necrosis, there was also extravascular localisation of trypanosomes. It is suggested that genital lesions in human sleeping sickness may have a similar pathogenetic mechanism involving tissue localisation of the trypanosomes and associated inflammatory and degenerative changes.

Entities:  

Mesh:

Year:  1979        PMID: 262595

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  3 in total

1.  Sperm morphological features associated with chronic Chagas disease in the semen of experimentally infected dogs.

Authors:  Olivia Rodríguez-Morales; Elvia Pedro-Martínez; José Ernesto Hernández-Pichardo; Ricardo Alejandre-Aguilar; Alberto Aranda-Fraustro; Verónica Graullera-Rivera; Minerva Arce-Fonseca
Journal:  Am J Trop Med Hyg       Date:  2014-08-11       Impact factor: 2.345

2.  Susceptibility of different breeds of goats in Kenya to experimental infection with Trypanosoma congolense.

Authors:  D D Whitelaw; G P Kaaya; J E Moulton; S K Moloo; M Murray
Journal:  Trop Anim Health Prod       Date:  1985-08       Impact factor: 1.559

3.  The effects of experimental Trypanosoma (Trypanozoon) (brucei) evansi infection on the fertility of male goats.

Authors:  J J Ngeranwa; E R Mutiga; G J Agumbah; P K Gathumbi; W K Munyua
Journal:  Vet Res Commun       Date:  1991       Impact factor: 2.459

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.